AK Medical Holdings Limited informed of the latest business development of the Company. The board of directors of the Company announced that the Group obtained the certification for the Trauma Custom Bridge Class III medical devices approved by the National Medical Products Administration of the People's Republic of China on 30 March 2023. The approved TCBridge of the Group is manufactured by titanium alloy material through additive manufacturing technology, and matched with the anatomic structure of the patient.

TCBridge is used for reconstruction treatment of large segment bone defects caused by trauma, tumor, infection, osteomyelitis. Based on the Group's Physician-Technician Interaction Platform, the product provides preoperative planning, Physician-Technician interaction, 3D printing customized design and manufacturing processing, and will finally be delivered to the clinic to complete the surgery. The product and its supporting technical process can assist doctors to complete the repair and reconstruction of complex large segmental bone defects of the limbs caused by a variety of reasons, helping patients to restore the anatomical and mechanical structure of the limb bones, regaining health and restoring normal work and life, and will benefit more patients.